Key points are not available for this paper at this time.
Current scientific evidence has proven that atherosclerosis is a process that begins in childhood and tracks into adulthood, likely culminating in adverse cardiovascular events such as coronary artery disease, peripheral artery disease, and stroke. In addition, the obesity epidemic and increasing awareness of genetic lipid disorders has made the understanding and management of lipid disorders necessary for pediatricians. Childhood offers a unique opportunity for preventing, modifying, or eliminating risk factors and, in doing so, reversing or slowing the process of atherosclerosis. In general, management involves targeted lifestyle interventions such as strict dietary changes and increases in physical activity. In some circumstances, pharmacotherapy, even in childhood, is warranted. Pediatr Ann . 2021;50(3):e105–e112.
“Early lipid screening beginning at 9-11 years of age enables earlier identification of dyslipidemia, including familial hypercholesterolemia (FH), offering opportunity for intervention prior to accumulation of atherogenic exposure.”
Leopold et al. (Mon,) studied this question.